Swiss All Share Index
16.669,46
PKT
+61,82
PKT
+0,37
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.07.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 23.07.12 | UBS neutral | UBS AG | |
| 23.07.12 | Meyer Burger Technology hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Julius Bär hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Sulzer buy | Sarasin Research | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | BB Biotech halten | Independent Research GmbH | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Sulzer buy | Vontobel Research | |
| 20.07.12 | Galenica reduce | Vontobel Research | |
| 20.07.12 | Clariant buy | Vontobel Research | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.07.12 | SGS SA buy | Vontobel Research | |
| 19.07.12 | Swisscom buy | Banc of America Securities-Merrill Lynch | |
| 19.07.12 | UBS overweight | J.P. Morgan Cazenove | |
| 19.07.12 | UBS hold | Deutsche Bank AG | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | UBS underperform | Exane-BNP Paribas SA | |
| 19.07.12 | Swisscom neutral | Nomura | |
| 19.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 19.07.12 | Logitech hold | Vontobel Research | |
| 19.07.12 | UBS equal-weight | Morgan Stanley | |
| 19.07.12 | Clariant buy | Vontobel Research | |
| 19.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 19.07.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | UBS hold | Vontobel Research | |
| 19.07.12 | UBS halten | Independent Research GmbH | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS neutral | Sarasin Research | |
| 18.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 18.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA |